Alievio is a cutting-edge medical device company based in Durham, NC, specializing in the development of personalized glaucoma treatments to prevent vision loss. With a team of renowned experts in ophthalmic surgery and ocular devices, Alievio aims to address the global prevalence of glaucoma, a serious eye disease that can lead to permanent blindness. Through innovative technology and a deep understanding of aqueous humor dynamics, Alievio is dedicated to slowing or halting the progression of glaucoma and improving the lives of millions affected by this condition. Led by Chief Scientific Officer Lucinda Camras, PhD, and Chief Medical Officer Sanjay Asrani, MD, Alievio combines scientific expertise with extensive clinical experience to develop effective solutions for glaucoma patients. With a focus on personalized treatment approaches and a commitment to ongoing research and development, Alievio is at the forefront of advancing glaucoma care and making a significant impact in the field of ophthalmology.
Generated from the website